Condition: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis · Sponsor: 89bio, Inc.
The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult participants with MASH.
This description comes directly from the study's public registry record.
Reference Study ID Number: BIO89-100-131 ENLIGHTEN clinical trial / No attachments to email below. · 888-662-6728 (U.S. Only) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| 89bio Clinical Study Site | Birmingham, Alabama, United States | Recruiting |
| 89bio Clinical Study Site | Chandler, Arizona, United States | Recruiting |
| 89bio Clinical Study Site | Flagstaff, Arizona, United States | Active Not Recruiting |
| 89bio Clinical Study Site | Glendale, Arizona, United States | Recruiting |
| 89bio Clinical Study Site | Sun City, Arizona, United States | Recruiting |
| 89bio Clinical Study Site | Tucson, Arizona, United States | Recruiting |
| 89bio Clinical Study Site | Conway, Arkansas, United States | Active Not Recruiting |
| 89bio Clinical Study Site | Little Rock, Arkansas, United States | Recruiting |
| 89bio Clinical Study Site | North Little Rock, Arkansas, United States | Recruiting |
| 89bio Clinical Study Site | Canoga Park, California, United States | Recruiting |
| 89bio Clinical Study Site | Coronado, California, United States | Recruiting |
| 89bio Clinical Study Site | Escondido, California, United States | Recruiting |
+ 349 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06318169